Our company will participate in CPHI China 2025 in Shanghai New International Expo Center from June
READ MORE 2025-04-17Company News | News List
2025 CPHI China on 24-26 Jun.2025, our booth E12D72
CStone completed a global multi-center Phase I clinical trial of CS2009 PD-1/VEGF/CTLA-4 tributary antibody
Preclinical studies have shown that the anti-tumor activity of CS2009 is superior to that of potenti
READ MORE 2025-03-22
[The world's only vaccine that can prevent cancer] Inventory: The rise of domestic HPV vaccine! Break the monopoly and welcome new opportunities in the 100 billion market
The research and development and market layout of domestic HPV vaccines are in a stage of rapid deve
READ MORE 2024-11-25
Journey Medical's rosacea drug Emrosi is approved by the FDA
On November 4, Journey Medical announced that the FDA has approved Emrosi™ (Minocycline hydrochlorid
READ MORE 2024-11-06
Roche has released new clinical data showing that monoclonal antibodies sustainably slow the progression of Parkinson's disease
Recently, Roche (Roche) researchers published in the international top medical journal Nature Medici
READ MORE 2024-10-19
Copd lung disease breakthrough! Successful Phase III study of GSK Mepolizumab
On September 6, GlaxoSmithKline (GSK) announced positive results from the Phase III MATINEE study of
READ MORE 2024-09-10
My first! The GSK RSV vaccine has been approved by the FDA to be extended to age 50-59
On June 7, GlaxoSmithKline (GSK) announced that the FDA approved Arexvy, a recombinant respiratory s
READ MORE 2024-06-12
Over $2 billion! Takeda introduces an anti-Aβ vaccine
On May 13, Takeda announced that it has entered into A worldwide exclusive option and license agreem
READ MORE 2024-05-17
Astrazeneca's "first-in-class" oral small molecule is approved by the FDA
On April 1, 2024, Astrazeneca announced the FDA approval of its "first-in-class" oral smal
READ MORE 2024-04-24
Nature Biotechnology | Antibody Drug Conjugators (ADCs) : ushering in a new era of precision cancer therapy
Recent studies have shown that by improving the linking technology and developing novel drug carrier
READ MORE 2024-03-15